Obermatt
See Similar Stocks →

Flags

Financial distress

Accuray

NSQ:ARAY · US0043971052
Health Care Equipment & SuppliesSmall

360

2
Profit price31
Owner Earnings Yield1
Dividend Yield1
Price/Sales100
EV / Gross Profit87
Price/Book41
Return on Capital63
Cash Return on Capital42
Return on Equity22
EBIT Margin62
Gross Profitability33
Accruals49
Owner Earnings Margin45
Sales growth4
Profit Growth91
Long-Term EPS Growth1
Owner Earnings Growth1
Reinvestment30
Price momentum4
Debt load13
Refinancing100
Debt Payback1
Liquidity47
Analyst ratings1
Opinion Changes4
Price Target Upside4
Market mood37
Value Creation0/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Accuray doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1990
Employees816
Websiteaccuray.com
ISINUS0043971052
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsNeurologyProcess AutomationBiomedical EngineeringArtificial IntelligenceOncologyCentral Nervous SystemSoftware DevelopmentHealth CareManufacturingMedical DeviceRetailSales

Description

Accuray Incorporated (Accuray) operates as a radiation therapy company. The company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments for even the most complex cases. The company’s…

Analysis

Middle-of-the-road

Accuray Incorporated sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is weak; the safety picture is fragile. The company scores 0/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
6
2023202420252026

All-time high

98

Jan 2024

All-time low

6

Jun 2026

Average rank

56

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
100
87
89
95
Price/Earnings
1
31
1
50
Price/Book
41
49
34
28
Dividend Yield
1
1
1
1
Value (overall)
60
58
48
61

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Accuray with its peers
AngioDynamics
NSQ:ANGO
57
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
PROCEPT BioRobotics
NMQ:PRCT
19
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Spectral AI
NAQ:MDAI
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
TransMedics Group
NMQ:TMDX
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Teleflex
NYQ:TFX
5
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
NeuroPace
NMQ:NPCE
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →